Nyse to commence delisting proceedings against global cord blood corporation (co)

New york--(business wire)--the new york stock exchange llc (“nyse” or “exchange”) announced today that the staff of nyse regulation has determined to commence proceedings to delist the ordinary shares of global cord blood corporation (the “company”) — ticker symbol co — from the nyse. trading in the company's ordinary shares will be suspended immediately. nyse regulation halted trading in the company's ordinary shares on september 23, 2022 and has now determined to commence delisting proceeding.
CO Ratings Summary
CO Quant Ranking